Page last updated: 2024-09-05

lasofoxifene and Urogenital Prolapse

lasofoxifene has been researched along with Urogenital Prolapse in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Pinkerton, JV; Stanczyk, FZ	1

Reviews

1 review(s) available for lasofoxifene and Urogenital Prolapse

Article	Year
Clinical effects of selective estrogen receptor modulators on vulvar and vaginal atrophy. Menopause (New York, N.Y.), 2014, Volume: 21, Issue:3 Topics: Atrophy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Indoles; Pelvic Organ Prolapse; Postmenopause; Pyrrolidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Treatment Outcome; Vagina; Vaginal Diseases; Vulva; Vulvar Diseases	2014

Article

Year

Clinical effects of selective estrogen receptor modulators on vulvar and vaginal atrophy.

Menopause (New York, N.Y.), 2014, Volume: 21, Issue:3

Topics: Atrophy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Indoles; Pelvic Organ Prolapse; Postmenopause; Pyrrolidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Treatment Outcome; Vagina; Vaginal Diseases; Vulva; Vulvar Diseases

2014